← Back to Search

Motor Imagery for Apraxia of Speech (MI-TEE Trial)

N/A
Recruiting
Led By Lauren Bislick Wilson, Ph.D.
Research Sponsored by University of Central Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Normal or corrected to normal visual acuity
Between the ages of 18 and 85 years old
Must not have
Unable to follow two-step commands and greater than moderate aphasia
Degenerative neurological illnesses
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from enrollment to the end of maintenance at 10 weeks, total of up to 23 weeks.
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to find a more affordable and accessible way to help individuals with post-stroke apraxia of speech (AOS) improve their speech. They want to create a computer-based program called

Who is the study for?
This trial is for individuals with speech difficulties due to conditions like dyspraxia or apraxia, specifically those who have had a stroke. It's designed to help improve their speech production through regular practice and therapy.
What is being tested?
The study tests a computer-based program called MI-TEE, used at home alongside standard speech therapy. The goal is to see if adding MI-TEE helps people get better at speaking more than just therapy alone.
What are the potential side effects?
Since the intervention involves non-invasive practices such as motor imagery and sound production exercises, no significant side effects are expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My vision is normal or corrected to normal with glasses or contacts.
Select...
I am between 18 and 85 years old.
Select...
I have been diagnosed with Apraxia of Speech.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I struggle to understand and follow simple instructions.
Select...
I have a condition that slowly worsens my brain or nerves.
Select...
My score on the Raven's test is below 23.
Select...
I have untreated depression or another psychiatric condition.
Select...
I have moderate to severe difficulty speaking.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from enrollment to the end of maintenance at 10 weeks, total of up to 23 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment to the end of maintenance at 10 weeks, total of up to 23 weeks. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Adherence rates
Rate of change
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Condition 2Experimental Treatment2 Interventions
Condition 2 will include two phases: (A) no treatment; (C) speech therapy plus MI-TEE (the home practice program).
Group II: Condition 1Experimental Treatment2 Interventions
Condition 1 will have three phases: (A) no treatment; (B) speech therapy alone; (C) speech therapy plus MI-TEE (the home practice program).

Find a Location

Who is running the clinical trial?

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
352 Previous Clinical Trials
181,171 Total Patients Enrolled
University of Central FloridaLead Sponsor
92 Previous Clinical Trials
1,120,258 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,811 Previous Clinical Trials
8,161,240 Total Patients Enrolled
~12 spots leftby Jul 2026